Abstract
Activation of transcription factors such as NF-κB occurs through signaling pathways involving sequential phosphorylation of a variety of substrates by distinct kinases. Proper assemby and activation of these kinases require interaction with non-enzymatic and essential partners named scaffold proteins. Here, we describe how the NF-κB activating scaffold proteins involved in the signaling pathways triggered by the proinflammatory cytokines TNFα, IL-1β and by the CD40 ligand play such roles. We also illustrate the human genetic diseases that are linked to mutations affecting genes coding for these proteins. We suggest that these scaffold proteins may be specifically targeted by novel therapeutical agents for the treatment of inflammation or cancers.
Keywords: scaffold proteins, ikk, nemo/ikk, genetic diseases, cancer, inflammation
Current Medicinal Chemistry
Title: NF-κB Activating Scaffold Proteins as Signaling Molecules and Putative Therapeutic Targets
Volume: 10 Issue: 7
Author(s): Alain Chariot, Marie-Alice Meuwis, Marianne Bonif, Antonio Leonardi, Marie-Paule Merville, Jacques Gielen, Jacques Piette, Ulrich Siebenlist and Vincent Bours
Affiliation:
Keywords: scaffold proteins, ikk, nemo/ikk, genetic diseases, cancer, inflammation
Abstract: Activation of transcription factors such as NF-κB occurs through signaling pathways involving sequential phosphorylation of a variety of substrates by distinct kinases. Proper assemby and activation of these kinases require interaction with non-enzymatic and essential partners named scaffold proteins. Here, we describe how the NF-κB activating scaffold proteins involved in the signaling pathways triggered by the proinflammatory cytokines TNFα, IL-1β and by the CD40 ligand play such roles. We also illustrate the human genetic diseases that are linked to mutations affecting genes coding for these proteins. We suggest that these scaffold proteins may be specifically targeted by novel therapeutical agents for the treatment of inflammation or cancers.
Export Options
About this article
Cite this article as:
Chariot Alain, Meuwis Marie-Alice, Bonif Marianne, Leonardi Antonio, Merville Marie-Paule, Gielen Jacques, Piette Jacques, Siebenlist Ulrich and Bours Vincent, NF-κB Activating Scaffold Proteins as Signaling Molecules and Putative Therapeutic Targets, Current Medicinal Chemistry 2003; 10 (7) . https://dx.doi.org/10.2174/0929867033457926
DOI https://dx.doi.org/10.2174/0929867033457926 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Novel Approaches for Inhibition of Mucus Hypersecretion in Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Two Promising Anti-Cancer Compounds, 2-Hydroxycinnaldehyde and 2- Benzoyloxycinnamaldehyde: Where do we stand?
Combinatorial Chemistry & High Throughput Screening Anti-Inflammatory Approaches to Reduce Acute Cardiovascular Events: Not Only Benefits
Current Pharmaceutical Biotechnology Oral Immune Regulation: A New Mode of Therapy Against Chronic Viral Infections
Recent Patents on Anti-Infective Drug Discovery Natural Bioactive Compounds against Oxidative Stress: Dietary Polyphenols Strike Back
Endocrine, Metabolic & Immune Disorders - Drug Targets Brain Cancer-Activated Microglia: A Potential Role for Sphingolipids
Current Medicinal Chemistry Subcategories of Fibromyalgia - A New Concept
Current Rheumatology Reviews Insight into Tissue Unbound Concentration: Utility in Drug Discovery and Development
Current Drug Metabolism Nitric Oxide and Dietary Factors: Part III Minerals, Vitamins and Other Dietary and Lifestyle Factors
Vascular Disease Prevention (Discontinued) PASylation as a Powerful Technology for Improving the Pharmacokinetic Properties of Biopharmaceuticals
Current Drug Delivery Importance of Influx and Efflux Systems and Xenobiotic Metabolizing Enzymes in Intratumoral Disposition of Anticancer Agents
Current Cancer Drug Targets Stressed to Death: Targeting Endoplasmic Reticulum Stress Response Induced Apoptosis in Gliomas
Current Pharmaceutical Design Design, Synthesis and Preliminary Evaluation of Novel Imperatorin Derivatives as Vasorelaxant Agents
Medicinal Chemistry A Review of Type 2 Diabetes Mellitus Predisposing Genes
Current Diabetes Reviews Wnt Signaling in Renal Cancer
Current Drug Targets Effects of Liver Diseases on Drug-metabolizing Enzymes: Implications for Drug Fate Alterations and Nano-therapeutic Openings
Current Medicinal Chemistry Granulocyte Colony-Stimulating Factor (G-CSF) for Cardio- and Cerebrovascular Regenerative Applications
Current Medicinal Chemistry Hypertension and Diabetes: Emphasis on the Renin-Angiotensin System in Atherosclerosis
Current Hypertension Reviews The Role of Melatonin in Pancreatic Protection: Could Melatonin be Used in the Treatment of Acute Pancreatitis?
Current Pharmaceutical Design